EXPANSE European Expansion of moveUP

Grant number: 961127

Grant search

Key facts

  • Disease

    COVID-19, Other
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $1,934,909.43
  • Funder

    EC (Horizon)
  • Principle Investigator

    Pending
  • Research Location

    N/A
  • Lead Research Institution

    MOVEUP
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

2020 will be remembered as year zero of tele-medicine. moveUP has developed a mobile health platform that monitors, informs and treats patients via standardised & validated protocols. Its first product is in orthopaedics, but with the Corona Crisis and the cancellation of all elective procedures, the platform has been extended to other pathologies. On 18/03, a monitoring protocol of suspected Covid19 patients has been offered to General Practitioners (GP), enabling them to follow-up symptoms of hundreds of patients, and intervene in case of need. The topic of this program remains orthopaedic joint replacements. But the benefits of the solution and its applicability for infectious or disabling diseases which restricts movement to the GP will be clear to the reader. Joint replacements are referred to as the surgery of the century, as the number are growing exponentially. But 20-30% of patients remain unsatisfied and quality of care is not measured. moveUP offers patients a safe, efficient and qualitative therapy to be made from the comfort of their home. It uses medical device certified machine learning models to adapt activity level, exercises, medication and coach patients, under uner supervision of healthcare providers. The therapy has shown in clinical studies to offer excellent outcomes, lower variability, and objective measure of quality, at a lower cost compared to standard of care. More than 1200 patients have been treated and it is the first digital therapy fully reimbursed by the national health insurance in Belgium. moveUP and has taken first steps to expand across Europe. But the fragmentation of the European Healthcare markets makes it more difficult for a start-up to scale and raise funding. The purpose of this application is to enable moveUP to adapt and certify its therapy in 4 target countries, run large scale pilots to demonstrate efficacy and health economic benefit, and to conclude partnerships with strategic partners to gain scale.